AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7614643
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg plus sodium citrate
Trial: 2693542
Drug: Lomefloxacin (LFLX)
DrugBank: Lomefloxacin (DB00978)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lomefloxacin (LFLX) 600 mg/day for 5 days
Trial: 2693542
Drug: Pipemidic acid
RxNorm normalized name: pipemidic acid
DrugBank: Pipemidic acid (DB13823)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pipemidic acid (PPA) 2000 mg/day for 5 days
Trial: 38806
Drug: Long-term neuroleptic
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term neuroleptic treatment (individually adjusted dosage)
Trial: 38806
Drug: Long-term neuroleptic
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term neuroleptic treatment
Trial: 28935470
Drug: RV5 (pentavalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RV5 (pentavalent live human-bovine reassortant rotavirus vaccine)
Trial: 23138396
Drug: N-acethyl-cysteine (NAC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acethyl-cysteine (NAC) 600 mg twice daily the day before and the day of the procedure plus 154 mmol NaHCO3 solution (B0) at a rate of 3 ml/kg/h from at least 2 h before the procedure and at 1 ml/kg/h during and for the next 6-12 h (BN group)
Trial: 23138396
Drug: 154 mmol
RxNorm normalized name: sodium chloride 0.154 MEQ/ML [Saljet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 154 mmol NaHCO3 solution (B0) at a rate of 3 ml/kg/h from at least 2 h before the procedure and at 1 ml/kg/h during and for the next 6-12 h (B0 group)
Trial: 23138396
Drug: N-acethyl-cysteine (NAC)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acethyl-cysteine (NAC) as above plus 154 mmol NaCl solution at a rate of 3 ml/kg/h from at least 2 h before the procedure and at 1 ml/kg/h during and for the next 6-12 h (SN group)
Trial: 19002646
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (LLLT) using two diode laser probes (660 nm, 6.2 J/cm², 6 min, continuous wave; 890 nm, 1 J/cm², 10 min, 1,500 Hz)
Trial: 19002646
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (placebo treatment, similar procedure without irradiation)
Trial: 10786260
Drug: Pharmacist outreach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist outreach program with academic detailing on ACE inhibitors and angiotensin II-receptor inhibitors for CHF.
Trial: 10786260
Drug: Patients treated
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Patients treated with an ACE inhibitor for CHF.
Trial: 8353101
Drug: Post-operative local
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative local chemotherapy (intraportal)
Trial: 8353101
Drug: Post-operative radiation
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-operative radiation therapy with chemotherapy
Trial: 8353101
Drug: Single agent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single agent systemic chemotherapy
Trial: 2874738
Drug: AC-DTP vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AC-DTP vaccine
Trial: 21538700
Drug: bihemispheric transcranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bihemispheric transcranial direct current stimulation and simultaneous physical/occupational therapy for five consecutive days
Trial: 16225490
Drug: Oral esomeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral esomeprazole
Trial: 7756468
Drug: Ritipenem acoxil
RxNorm normalized name: Imipenem
DrugBank: Imipenem (DB01598)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritipenem acoxil (500 mg three times daily)
Trial: 7756468
Drug: Norfloxacin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norfloxacin (200 mg twice daily)
Trial: 2144788
Drug: 0.18 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.18 mg/kg ondansetron (high dose)
Trial: 2144788
Drug: 0.01 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg/kg ondansetron (low dose)
Trial: 7286585
Drug: Cabernet Sauvignon
RxNorm normalized name: diphenhydramine
DrugBank: Diphenhydramine (DB01075)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cabernet Sauvignon (mean ethanol concentration = 9500 mg/dl)
Trial: 7286585
Drug: Low-alcohol Cabernet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-alcohol Cabernet Sauvignon (mean ethanol concentration = 1312 mg/dl)
Trial: 29071331
Drug: Dalcetrapib, 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalcetrapib, 600 mg daily
Trial: 22537990
Drug: Healive (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healive (one dose)
Trial: 22537990
Drug: Havrix (one
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Havrix (one dose)
Trial: 22537990
Drug: Healive (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healive (two doses)
Trial: 22537990
Drug: Havrix (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Havrix (two doses)
Trial: 22537990
Drug: Healive-Havrix (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healive-Havrix (two doses)
Trial: 22537990
Drug: Havrix-Healive (two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Havrix-Healive (two doses)
Trial: 17566515
Drug: Glucan solution
RxNorm normalized name: BETA GLUCAN
DrugBank: Yeast beta-D-glucan (DB19271)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucan solution nasal spray
Trial: 11996634
Drug: Newer antidepressant
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Newer antidepressant medications (including serotonergic antidepressants and buspirone)
Trial: 11996634
Drug: Benzodiazepines and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzodiazepines and tricyclic antidepressants (TCAs)
Trial: 10488969
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (400 IU daily for 8 weeks)
Trial: 8730557
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy plus drug resistance modifying agents such as cyclosporins
Trial: 6861873
Drug: Controlled release
RxNorm normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled release (CR) formulation of indomethacin 75 mg (Indocid‐Retard) given once daily
Trial: 6861873
Drug: Conventional 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional 25 mg indomethacin capsule (Indocid) given 3 times daily
Trial: 31730506
Drug: Community-based interventions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community-based interventions (exercise, medication, nutritional management, improving safety of the local environment)
Trial: 29381666
Drug: CEE plus
RxNorm normalized name: Ecee Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE plus MPA (2.5 mg/d)
Trial: 29381666
Drug: CEE plus
RxNorm normalized name: Ecee Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE plus MPA (2.5 mg/d) postintervention
Trial: 29381666
Drug: CEE (0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE (0.625 mg/d) postintervention
Trial: 1776335
Drug: Molsidomine (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Molsidomine (16 mg, slow-release formulation)
Trial: 31869756
Drug: Standardised medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardised medical (including psychiatric) care + cognitive behavioural therapy for dissociative seizures (part of the CODES trial)
Trial: 17060331
Drug: Propofol 4
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol 4 mug ml(‐1)
Trial: 10701625
Drug: 250 mg/ml
RxNorm normalized name: urea 250 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg/ml (1250)
Trial: 10701625
Drug: 300 mg/ml
RxNorm normalized name: urea 300 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/ml (1300)
Trial: 10701625
Drug: 350 mg/ml
RxNorm normalized name: urea 350 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 350 mg/ml (1350)
Trial: 3028362
Drug: Beta Interferon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta Interferon cream (20,000 iu/g)
Trial: 24311828
Drug: Wu-Ling-San (WLS)
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wu-Ling-San (WLS) formula, 2 gm three times daily for 1 month
Trial: 24311828
Drug: Placebo, 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 2 gm three times daily for 1 month
Trial: 21865574
Drug: ATRA (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATRA (20 mg/m²/d)
Trial: 21865574
Drug: ATRA (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ATRA (20 mg/kg PO) in animal model
Trial: 19659873
Drug: Oral procyanidin
RxNorm normalized name: procyanidin A2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral procyanidin + vitamins A, C, E
Trial: 11843249
Drug: SIR-Spheres plus
RxNorm normalized name: INCONT BRIEF SIR DIGNITY PLUS LARGE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SIR-Spheres plus chemotherapy (HAC)
Trial: 9684188
Drug: Oral specific
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral specific hyposensitization treatment
Trial: 7849967
Drug: Fluosol DA-20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluosol DA-20% (FDA) intravenous infusion at 30 cc/kg
Trial: 7849967
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no FDA treatment)
Trial: 29180457
Drug: β-blocker (Bbl)
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: β-blocker (Bbl)
Trial: 16783479
Drug: AM-24 (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM-24 (500 mg once daily)
Trial: 16783479
Drug: AM-24 (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AM-24 (240 mg and 350 mg doses also administered)
Trial: 8445423
Drug: Tamoxifen plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen plus fenretinide 100, 200, 300, or 400 mg/d
Trial: 29861249
Drug: Zumba dancing
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zumba dancing performed twice a week for 12 weeks
Trial: 23902955
Drug: PDF (per
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDF (per 100 mL: 67 kcal, 1.7 g protein, 65 mg calcium, 38 mg phosphorus, 56 IU vitamin D)
Trial: 23902955
Drug: TF (per
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TF (per 100 mL: 67 kcal, 1.47 g protein, 50 mg calcium, 30 mg phosphorus, 48 IU vitamin D)
Trial: 14708472
Drug: Basal (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal (no treatment)
Trial: 3623787
Drug: Reinfusion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinfusion of autologous blood (1350 ml)
Trial: 31691053
Drug: Ozone therapy
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone therapy (G2, n = 26), generator probe type 3, working time per point 5 s, 23 points, application time 1 min and 55 s
Trial: 21118369
Drug: HA330 hemoperfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA330 hemoperfusion treatment (N=24)
Trial: 21118369
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (N=20)
Trial: 14600520
Drug: TMC125 (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TMC125 (900 mg twice daily for 7 days)
Trial: 10080589
Drug: Capecitabine at
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Capecitabine at 2,510 mg/m2/d for 2 weeks followed by a 1-week rest period, repeated in 3-week cycles.
Trial: 7813270
Drug: Aerosolized norepinephrine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized norepinephrine (NE) 0.04 mg
Trial: 1763589
Drug: Indomethacin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (25 mg bolus followed by 5 mg infusion over 1 h) + TENS (low or high frequency)
Trial: 6410971
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (TRH) 1 mg intravenously as a bolus dose, followed by 1 mg infused over 5 minutes, then 1 mg intravenously every 12 hours for 3 days
Trial: 28960164
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy for Insomnia (CBTI) delivered by a supervised sleep educator
Trial: 27329400
Drug: Sildenafil 20
RxNorm normalized name: sildenafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil 20 mg, 3 times a day for 16 weeks
Trial: 23873891
Drug: Bimatoprost ophthalmic
RxNorm normalized name: bimatoprost ophthalmic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bimatoprost ophthalmic solution 0.03%
Trial: 21914755
Drug: Sham group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham group (2 mL 0.9% saline)
Trial: 21914755
Drug: Epidural saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural saline group (30 mL 0.9% saline)
Trial: 21914755
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid group (40 mg triamcinolone acetonide in 29 mL 0.9% saline)
Trial: 19052125
Drug: Peginterferon alfa-2a
RxNorm normalized name: Peginterferon Alfa-2A
DrugBank: Peginterferon alfa-2a (DB00008)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa-2a at a dosage of 90 microg per week for 3.5 years
Trial: 16801668
Drug: Folate 1
RxNorm normalized name: Elfolate 15mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Folate 1 mg/vitamin B(12) 500 microg
Trial: 11061655
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose therapy with zidovudine, lamivudine, and indinavir
Trial: 9357394
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg seratrodast
Trial: 9357394
Drug: 120 mg
RxNorm normalized name: papain 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 120 mg seratrodast
Trial: 8260471
Drug: 0.3 g
RxNorm normalized name: sorbitol 0.3 GM Oral Lozenge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 g protein/kg per d
Trial: 8260471
Drug: 0.4 g
RxNorm normalized name: psyllium 0.4 GM Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 g protein/kg per d
Trial: 8260471
Drug: 0.5 g
RxNorm normalized name: Gelatin Capsules, 10.5 gr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 g protein/kg per d
Trial: 8260471
Drug: 0.6 g
RxNorm normalized name: Ceo-Two, 0.9 g-0.6 g rectal suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 g protein/kg per d
Trial: 26860802
Drug: Traditional Chinese
RxNorm normalized name: BORNEOL 1 g in 6.5 g / MINT 1 g in 6.5 g / ANGELICA DAHURICA ROOT 0.5 g in 6.5 g TOPICAL POWDER [Traditional Chinese Medicine Health Card and TCM Epidemic Prevention Card]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional Chinese Medicine (TCM) treatment (herbal injection (Cinobufacini, 20ml/d, d1-d10), herbal decoction (d1-d21), Chinese acupoint application (d1-d21))
Trial: 26860802
Drug: Chemotherapy (pemetrexed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (pemetrexed (500mg/m(2), d1), docetaxel (75mg/m(2), d1) or gemcitabine (1250mg/m(2), d1 and d8))
Trial: 20829132
Drug: Ezetimibe (EZM)
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe (EZM) preparation 1
Trial: 20829132
Drug: Ezetimibe (EZM)
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe (EZM) preparation 2
Trial: 16866719
Drug: Topiramate (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (mean dose 124.7 mg/d)
Trial: 12811613
Drug: Infrared lasertherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infrared lasertherapy - Group L; n=20
Trial: 10743866
Drug: 25% metronidazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% metronidazole gel applied during periodontal surgery
Trial: 10743866
Drug: Surgery +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery + 25% metronidazole gel
Trial: 9184738
Drug: Granisetron (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (1 mg tablets/2 mg dose)
Trial: 9184738
Drug: Ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron (8 mg tablets/8 mg dose)
Trial: 9184738
Drug: Prochlorperazine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prochlorperazine (10 mg tablets/10 mg dose)
Trial: 1524898
Drug: Breast-conserving therapy
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast-conserving therapy (BCT) - lumpectomy, axillary clearance, and radiotherapy (50 Gy in 5 weeks external irradiation and a boost with iridium implant of 25 Gy)
Trial: 1524898
Drug: Salvage treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salvage treatment for local recurrence
Trial: 31356921
Drug: ASN002 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASN002 (20 mg)
Trial: 31356921
Drug: ASN002 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASN002 (40 mg)
Trial: 31356921
Drug: ASN002 (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ASN002 (80 mg)
Trial: 26259770
Drug: Intramyocardial injection
RxNorm normalized name: ALCOHOL 80 mL in 100 mL INTRAEPICARDIAL LIQUID [80% Alcohol Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramyocardial injection of 100×10(6) autologous bone marrow mononuclear cells
Trial: 23329566
Drug: Health facilities
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health facilities with adequate staffing and availability of medical equipment and medications
Trial: 21521310
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg and cholecalciferol 5600 IU (RSD+)
Trial: 21521310
Drug: Risedronate 35
RxNorm normalized name: risedronate 35 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate 35 mg alone (RSD)
Trial: 18645245
Drug: Soft-gel capsules
RxNorm normalized name: Fortovase 200 MG Soft-Gel Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft-gel capsules with CoQ10 in soybean oil (reference)
Trial: 16155071
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (600 microg every 3 h for a maximum of three doses)
Trial: 16155071
Drug: Extended course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended course of sublingual misoprostol (400 microg daily for 1 week)
Trial: 16155071
Drug: Extended course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended course of sublingual misoprostol
Trial: 11219162
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation and measles vaccine interaction
Trial: 8808520
Drug: KCl (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: KCl (7 mEq in 200 mL of 0.9% NaCl)
Trial: 8808520
Drug: MgSO4 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MgSO4 (10 mL 20% in 200 mL of 0.9% NaCl)
Trial: 8808520
Drug: Procainamide (maximal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procainamide (maximal dose, 10 mg/kg of body weight over a 5‐minute period)
Trial: 8808520
Drug: NaCl (0.9%,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NaCl (0.9%, 200 mL)
Trial: 1329220
Drug: Combination carboplatin/etoposide/vincristine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination carboplatin/etoposide/vincristine (CEV)
Trial: 4057572
Drug: PAV therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAV therapy in stage IV cases
Trial: 4057572
Drug: PAV therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PAV therapy in operable cases
Trial: 4057572
Drug: Bestatin treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bestatin treatment in stage Ib and II cases
Trial: 4057572
Drug: PPSM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPSM treatment with prophylactic lymph node dissection
Trial: 4057572
Drug: PPSM treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPSM treatment without prophylactic lymph node dissection
Trial: 30366505
Drug: Adaptive Iterative
RxNorm normalized name: ADAPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adaptive Iterative Dose Reduction 3D (AIDR3D) with 80 kV and auto mA (Group B)
Trial: 24731889
Drug: Osteopathic sham
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic sham therapy